MedTrace Logo

Examining Effects of Tysabri on Cognitive Fatigue Using fMRI

NCT04565431 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2024-02-15

No results posted yet for this study

Summary

The purpose of this research study is to investigate the effectiveness of Tysabri on cognitive fatigue in persons with Relapsing-Remitting Multiple Sclerosis (RRMS). Cognitive fatigue is the kind of fatigue that occurs after intense mental concentration as after a session of problem solving.

Conditions

  • Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG

Tysabri

Participants with RRMS who are planning to begin treatment with Tysabri will be compared to a group of healthy individuals who are matched for age, gender, and education.

Sponsors & Collaborators

  • St. Barnabas Medical Center

    collaborator OTHER

  • Kessler Foundation

    lead OTHER

Principal Investigators

  • John DeLuca, Ph.D. · Kessler Foundation

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-19
Primary Completion
2024-12-31
Completion
2024-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04565431 on ClinicalTrials.gov